BRPI0913986A2 - composto, composição farmacêutica, e, uso de um composto - Google Patents
composto, composição farmacêutica, e, uso de um compostoInfo
- Publication number
- BRPI0913986A2 BRPI0913986A2 BRPI0913986A BRPI0913986A BRPI0913986A2 BR PI0913986 A2 BRPI0913986 A2 BR PI0913986A2 BR PI0913986 A BRPI0913986 A BR PI0913986A BR PI0913986 A BRPI0913986 A BR PI0913986A BR PI0913986 A2 BRPI0913986 A2 BR PI0913986A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008079901 | 2008-03-26 | ||
PCT/JP2009/055738 WO2009119534A1 (ja) | 2008-03-26 | 2009-03-24 | 新規テトラヒドロイソキノリン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0913986A2 true BRPI0913986A2 (pt) | 2015-10-20 |
Family
ID=41113726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0913986A BRPI0913986A2 (pt) | 2008-03-26 | 2009-03-24 | composto, composição farmacêutica, e, uso de um composto |
Country Status (17)
Country | Link |
---|---|
US (1) | US8735425B2 (pt) |
EP (1) | EP2256105B1 (pt) |
JP (2) | JP4531127B2 (pt) |
KR (1) | KR20100124771A (pt) |
CN (1) | CN101981012A (pt) |
AU (1) | AU2009230127B2 (pt) |
BR (1) | BRPI0913986A2 (pt) |
CA (1) | CA2719721C (pt) |
CO (1) | CO6251285A2 (pt) |
IL (1) | IL208168A (pt) |
MX (1) | MX2010010471A (pt) |
MY (1) | MY161992A (pt) |
NZ (1) | NZ587630A (pt) |
RU (1) | RU2474575C2 (pt) |
TW (1) | TW200944505A (pt) |
WO (1) | WO2009119534A1 (pt) |
ZA (1) | ZA201006563B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2402317B1 (en) | 2006-03-31 | 2013-07-03 | Novartis AG | DGAT inhibitor |
AR066169A1 (es) | 2007-09-28 | 2009-07-29 | Novartis Ag | Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat |
RU2474575C2 (ru) * | 2008-03-26 | 2013-02-10 | Дайити Санкио Компани, Лимитед | Новое производное тетрагидроизохинолина, фармацевтическая композиция на его основе, применение его и способ лечения и/или предотвращения заболевания |
EP2328871B1 (en) | 2008-08-25 | 2020-04-01 | Novartis AG | Hedgehog pathway modulators |
IN2012DN01203A (pt) * | 2009-08-28 | 2015-04-10 | Daiichi Sankyo Co Ltd | |
SG183529A1 (en) * | 2010-03-30 | 2012-10-30 | Novartis Ag | Uses of dgat1 inhibitors |
FR2963005B1 (fr) * | 2010-07-23 | 2012-08-17 | Sanofi Aventis | Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1077173A (en) | 1965-03-19 | 1967-07-26 | American Cyanamid Co | Substituted alkylene piperidines and methods of preparation thereof |
NL7800026A (nl) | 1977-01-07 | 1978-07-11 | Acna | Werkwijze voor de bereiding van gesubstitueerde amino-benzenen. |
GB8609630D0 (en) | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
US20010009912A1 (en) | 1995-02-10 | 2001-07-26 | Christos Tsaklakidis | New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds |
DZ2769A1 (fr) | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Composés tricycliques substitués. |
JP2000026294A (ja) | 1998-05-07 | 2000-01-25 | Sankyo Co Ltd | アリ―ルウレア又はアリ―ルメチルカルバモイル誘導体を含有する医薬 |
GB0028483D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Hydroxyethylamine HIV protease inhibitors |
MXPA01012317A (es) | 2000-12-28 | 2002-07-22 | Warner Lambert Co | Prueba de aciltransferasa del diacilglicerol (dgat). |
US20020127626A1 (en) * | 2001-01-05 | 2002-09-12 | Sensors For Medicine And Science, Inc. | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
WO2003007955A2 (en) | 2001-07-20 | 2003-01-30 | Cancer Research Technology Limited | Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer |
MY133406A (en) | 2001-11-28 | 2007-11-30 | Ipsen Pharma Sas | 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
JP4231999B2 (ja) | 2002-12-19 | 2009-03-04 | ダイキン工業株式会社 | ω−ヨウ化含フッ素アルキルビニルエーテルの製造方法 |
US7328301B2 (en) * | 2003-04-07 | 2008-02-05 | Intel Corporation | Dynamically mapping block-alterable memories |
JP2006528180A (ja) * | 2003-07-22 | 2006-12-14 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン−4受容体作働薬としてのピペリジン誘導体 |
WO2005011656A2 (en) | 2003-07-30 | 2005-02-10 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
JP4110324B2 (ja) | 2003-10-15 | 2008-07-02 | 宇部興産株式会社 | 新規インダゾール誘導体 |
JP2007519605A (ja) | 2004-01-30 | 2007-07-19 | 日本たばこ産業株式会社 | 食欲抑制薬 |
DK1761520T3 (da) | 2004-06-23 | 2008-10-27 | Lilly Co Eli | Kinaseinhibitorer |
WO2006004200A1 (ja) * | 2004-07-02 | 2006-01-12 | Sankyo Company, Limited | ウレア誘導体 |
JP2006045209A (ja) | 2004-07-02 | 2006-02-16 | Sankyo Co Ltd | ウレア誘導体 |
WO2006019020A1 (ja) | 2004-08-16 | 2006-02-23 | Sankyo Company, Limited | 置換されたウレア化合物 |
JP2008521847A (ja) | 2004-12-03 | 2008-06-26 | エフ.ホフマン−ラ ロシュ アーゲー | H3拮抗剤としての3−置換ピリジン誘導体 |
JPWO2006095922A1 (ja) * | 2005-03-10 | 2008-08-21 | 京都薬品工業株式会社 | テトラヒドロイソキノリン化合物およびその医薬用途 |
JP2007131584A (ja) | 2005-11-11 | 2007-05-31 | Sankyo Co Ltd | 新規ベンゾオキサゾール誘導体 |
JP2007191471A (ja) * | 2005-12-21 | 2007-08-02 | Sankyo Co Ltd | ウレア誘導体を含有する医薬 |
WO2007074753A1 (ja) | 2005-12-27 | 2007-07-05 | Daiichi Sankyo Company, Limited | 置換されたウレア誘導体を含有する医薬 |
EP1837332A1 (en) * | 2006-03-23 | 2007-09-26 | Laboratorios Del Dr. Esteve, S.A. | Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
RU2474575C2 (ru) * | 2008-03-26 | 2013-02-10 | Дайити Санкио Компани, Лимитед | Новое производное тетрагидроизохинолина, фармацевтическая композиция на его основе, применение его и способ лечения и/или предотвращения заболевания |
-
2009
- 2009-03-24 RU RU2010143586/04A patent/RU2474575C2/ru not_active IP Right Cessation
- 2009-03-24 AU AU2009230127A patent/AU2009230127B2/en not_active Ceased
- 2009-03-24 WO PCT/JP2009/055738 patent/WO2009119534A1/ja active Application Filing
- 2009-03-24 EP EP09725300.9A patent/EP2256105B1/en not_active Not-in-force
- 2009-03-24 MY MYPI2010004025A patent/MY161992A/en unknown
- 2009-03-24 KR KR1020107020729A patent/KR20100124771A/ko not_active Application Discontinuation
- 2009-03-24 MX MX2010010471A patent/MX2010010471A/es active IP Right Grant
- 2009-03-24 BR BRPI0913986A patent/BRPI0913986A2/pt not_active IP Right Cessation
- 2009-03-24 JP JP2010505647A patent/JP4531127B2/ja not_active Expired - Fee Related
- 2009-03-24 NZ NZ587630A patent/NZ587630A/en not_active IP Right Cessation
- 2009-03-24 CA CA2719721A patent/CA2719721C/en not_active Expired - Fee Related
- 2009-03-24 CN CN2009801125321A patent/CN101981012A/zh active Pending
- 2009-03-25 TW TW098109649A patent/TW200944505A/zh unknown
-
2010
- 2010-05-13 JP JP2010110895A patent/JP2010215640A/ja active Pending
- 2010-09-09 US US12/878,170 patent/US8735425B2/en not_active Expired - Fee Related
- 2010-09-13 ZA ZA2010/06563A patent/ZA201006563B/en unknown
- 2010-09-15 IL IL208168A patent/IL208168A/en not_active IP Right Cessation
- 2010-10-22 CO CO10131510A patent/CO6251285A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2719721C (en) | 2012-12-18 |
EP2256105A4 (en) | 2011-09-14 |
MY161992A (en) | 2017-05-31 |
EP2256105A1 (en) | 2010-12-01 |
US8735425B2 (en) | 2014-05-27 |
AU2009230127A1 (en) | 2009-10-01 |
JPWO2009119534A1 (ja) | 2011-07-21 |
EP2256105B1 (en) | 2013-12-04 |
KR20100124771A (ko) | 2010-11-29 |
CA2719721A1 (en) | 2009-10-01 |
CN101981012A (zh) | 2011-02-23 |
MX2010010471A (es) | 2010-10-20 |
CO6251285A2 (es) | 2011-02-21 |
AU2009230127B2 (en) | 2011-12-22 |
JP4531127B2 (ja) | 2010-08-25 |
TW200944505A (en) | 2009-11-01 |
JP2010215640A (ja) | 2010-09-30 |
ZA201006563B (en) | 2011-10-26 |
WO2009119534A1 (ja) | 2009-10-01 |
NZ587630A (en) | 2011-07-29 |
RU2010143586A (ru) | 2012-05-10 |
IL208168A (en) | 2013-04-30 |
US20110034481A1 (en) | 2011-02-10 |
IL208168A0 (en) | 2010-12-30 |
RU2474575C2 (ru) | 2013-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0917001A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
BRPI0918360A2 (pt) | composto, composição farmacêutica e usos de um composto | |
BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
BRPI0915134A2 (pt) | composto, e, uso de um composto | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BRPI0919165A2 (pt) | composição farmacêutica,e, uso de um composto | |
BRPI0915473A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |